Lineage Cell Therapeutics Shares Rise 12% After Collaboration with Roche, Genentech
By Mary de Wet Lineage Cell Therapeutics Inc. shares rose 12% to $2.37 in premarket trade ...
Read moreBy Mary de Wet Lineage Cell Therapeutics Inc. shares rose 12% to $2.37 in premarket trade ...
Read more© 2022 TheDailyStock.News